However, RET screening allowed us to identify unsuspected germline RET mutations in 23 of the 54 MTC patients (43%) who appeared to present as sporadic disease cases, according to their negative family histories and isolated MTC phenotype (Table 2). The gene discussed is RET; the disease is medullary thyroid gland carcinoma.